about
Intrathymic function of the human cortical epithelial cell surface antigen gp200-MR6: single-chain antibodies to evolutionarily conserved determinants disrupt mouse thymus developmentAspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cellsModulation of hydrogen peroxide induced injury to corneal endothelium by virus mediated catalase gene transfer.Identification of synovium-specific homing peptides by in vivo phage display selection.Reconstruction of cell population dynamics using CFSECytokines, chaos, and complexity.Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.Thymic involution with ageing: obsolescence or good housekeeping?Targeting of anti-tumor responses with bispecific antibodies.Corneal transplantation: the forgotten graft.Arginine depletion as a mechanism for the immune privilege of corneal allografts.A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor.Understanding specificity and sensitivity of T-cell recognition.The evolving role of gene-based treatment in surgery.Gene therapy for clinical transplantation: where do we stand in 2006?Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization.Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats.Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.Anti-idiotypic therapy of leukemias and lymphomas.Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide.Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.Xenon Treatment Protects against Remote Lung Injury after Kidney Transplantation in Rats.Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats.Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection.Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats.Knockdown of mouse VCAM-1 by vector-based siRNA.Detection of vascular expression of E-selectin in vivo with MR imaging.Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin.Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.Demonstration of IgM antibodies of high affinity within the anti-Galalpha1-3Gal antibody repertoire.Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography.Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.A sensitive fluorometric assay for determining hydrogen peroxide-mediated sublethal and lethal endothelial cell injury.A method for determining the cytoprotective effect of catalase in transiently transfected cell lines and in corneal tissue.Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells.Single-chain Fv radioimmunotargeting.Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin.Distribution of integrins alpha v beta 5, alpha v beta 3 and alpha v in normal human cornea: possible implications in clinical and therapeutic adenoviral infection.Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies
P50
Q24643035-D96DC116-0761-416D-BF2C-9176F65C2DE5Q28217614-A028A961-9732-4F38-9F4E-F8541972FD95Q30843670-1022BD95-1174-4060-A510-B0E34D5E1E22Q31107560-F0ABAAB3-6153-4237-862D-0E3FC7852ADEQ33287503-D98C76C8-44A8-4DF9-A240-5B83777A1E65Q33790709-A8CFB0D2-943C-4D92-BC3C-C78495BA259CQ33972355-00295298-2F5B-48AD-8635-1400CC2DC53AQ34410911-EEDBCBA3-1B9E-4920-8079-4C2E839E6DABQ35548537-6408EF02-F5BC-4D06-9E30-49746A2408CEQ35745697-7117AE19-B0BF-4C72-B91B-A10E16C21727Q36043930-A9CA0899-CB87-4263-8895-D208C0A5A956Q36266269-5E3F0ACB-3F9E-4066-BE51-269E49273939Q36291217-9F2361DD-0C3D-4930-BD4A-2BDD9436FB59Q36307508-C6737CDA-8698-442D-9874-D2E4CF6493E2Q36711725-03768F10-9C85-46BD-BD66-6F87CF1325B4Q37393524-C954A678-2A86-493E-B9AB-7157D02C30F1Q37449283-0CC459B0-DFBA-4F42-B9B7-602E4D8F575BQ37707474-14B10DB6-AC71-416B-A635-81581BDD13B6Q38137853-23AB0B6A-7F05-4C59-8624-9AA440893638Q38358463-5551542F-CFEE-4E7C-8EC4-9170F3557F57Q38888264-FACFA2D3-2D4C-46AF-9701-9DC519224F3EQ38889407-0272D50B-2698-4DCE-BBA1-4E03FAC4E5F8Q39050794-A6598619-430F-4C26-A2C8-B0507AC33F93Q39097123-539F4BFE-2FAA-45AF-8526-EA0A7FC6D630Q39121226-996BB78C-7FB4-448C-88F9-5950D85CB5A6Q39140580-AD40F732-94AE-4839-A8D8-BA071A579F40Q40202408-A05C7B5F-25EA-482B-95B2-4B2E7445128AQ40226814-64D7F446-C051-4F8C-902C-13F084981BEDQ40246390-B00181F7-58BC-488A-B60B-4E3C3B130D5EQ40413098-ACF1F595-AF30-4DCB-A969-D9406B70B76BQ40836105-079816A5-3525-4870-8397-48B89215DDD9Q40836111-02FC06DE-26AA-4293-85BE-0E6085F83245Q40904129-3167899D-C8EF-427E-9235-0B52476849B6Q40975868-756E94F6-577A-400E-9479-F672C82CD9CBQ40978171-2B3CC3F5-18C0-40ED-A2B8-A2000BE0F7ADQ41171963-2DEA00F5-6F20-453A-B9B9-5DF200FEDAB6Q41266269-9BF1E18E-27AD-4E8D-AAAF-4A49206E49CCQ41688677-41FBEA4C-70A1-41F7-A276-8E757CDC0492Q42458932-9ED808DD-6EA2-43E0-B8A9-E810D683CBA1Q42590633-7D3DDE0D-9026-4CCB-B4A9-788B2B70B2FB
P50
description
researcher ORCID ID = 0000-0002-2866-0241
@en
wetenschapper
@nl
name
Andrew George
@ast
Andrew George
@en
Andrew George
@es
Andrew George
@nl
type
label
Andrew George
@ast
Andrew George
@en
Andrew George
@es
Andrew George
@nl
prefLabel
Andrew George
@ast
Andrew George
@en
Andrew George
@es
Andrew George
@nl
P1153
35509259800
P31
P496
0000-0002-2866-0241